Чому обрати Республіку Корея для радіотерапії раку горла?
Отримайте доступ до передових рішень радіотерапії для раку горла у надійних клініках .
| Південна Корея | Туреччина | Україна | |
| Променева терапія при раку гортані | - | від $3,250 | - |
Ви не сплачуєте за послуги Bookimed. Ціни на променеву терапію при раку гортані відповідають прайс-листу клініки. Оплата безпосередньо в клініці. Доступна оплата частинами.
Bookimed піклується про вашу безпеку. Ми співпрацюємо лише з медичними закладами, які дотримуються високих міжнародних стандартів у проведенні променевої терапії при раку гортані та мають необхідні ліцензії для обслуговування пацієнтів з різних країн.
Bookimed надає безкоштовну експертну підтримку. Особистий лікар-координатор супроводжує вас до, під час та після процедур, вирішуючи будь-які питання. Ви ніколи не залишитеся наодинці під час процедури Променева терапія при раку гортані в іншій країні.
День 1
день 2
день 3
День 4
Тиждень 1 - Тиждень 7
8 тиждень
Тиждень 9 - Тиждень 12
13 тиждень і далі
Будь ласка, зверніть увагу, що план лікування кожного пацієнта та графік відновлення можуть відрізнятися залежно від тяжкості захворювання, загального стану здоров’я та реакції на лікування.
Доктор Чой Ду Кхо має понад 25 років досвіду в кардіохірургії, набутого в Медичному центрі Samsung.
Доктор Син Джe Хо — онколог Медичного центру Samsung, який спеціалізується на променевій терапії раку горла.
Професор Лім До Хун очолює Відділення радіаційної онкології в Медичному центрі Самсунг, спеціалізуючись на прецизійній променевій терапії.
Спеціалізується на променевій терапії раку гортані у Медичному центрі «Самсунг».
The Republic of Korea offers world-class radiation technologies including carbon-ion therapy, proton beam therapy (PBT), and MR-Linac systems. Patients access precision photon therapies like Intensity-Modulated Radiation Therapy (IMRT) and robotic CyberKnife at JCI-accredited facilities. These advanced modalities minimize damage to healthy tissues in complex throat cancer cases.
Bookimed Expert Insight: Samsung Medical Center stands out by offering adaptive radiotherapy replanning mid-course. While many clinics use a fixed plan, this data-driven approach adjusts for throat swelling or weight loss. This specific flexibility significantly reduces long-term side effects like dry mouth and swallowing difficulties.
Patient Consensus: Patients value how proton therapy provides sharper targeting for head and neck cases. Many emphasize that having English-speaking coordinators is essential for managing the technical scheduling of these advanced treatments.
A standard course of radiotherapy for throat cancer typically lasts 6 to 7 weeks. This curative schedule involves sessions once per day, 5 days per week, totaling 30 to 35 treatments. Palliative regimens for symptom relief generally conclude within 1 to 3 weeks.
Bookimed Expert Insight: Samsung Medical Center and Asan Medical Center utilize advanced technologies like Novalis and IGRT to maximize precision. Data shows South Korea maintains high cancer survival rates by following strict international protocols. Clinics like Samsung accommodate over 2,000,000 patients annually, ensuring deep expertise in complex head and neck cases.
Patient Consensus: Fatigue and swallowing difficulties typically peak around week 3 or 4. Patients emphasize that weekend breaks are vital for managing side effects before the final sessions.
Success rates for throat cancer treatment in Korea are among the highest globally, with early-stage laryngeal cancer showing 5-year survival rates between 75% and 95%. Advanced cases (Stages III-IV) achieve approximately 30% to 52% survival through modern radiotherapy and multidisciplinary protocols at JCI-accredited centers in Seoul.
Bookimed Expert Insight: While many countries focus on surgery, Korean centers like Severance Hospital and Samsung Medical Center emphasize laryngeal preservation. Data shows high success by combining IGRT with chemotherapy. This approach maintains voice function without compromising the 85% to 90% surgical efficacy rates reported in Seoul.
Patient Consensus: Patients value the thoroughness of Korean oncologists and the availability of proton therapy to limit side effects. Many note that concurrent chemoradiotherapy is intense but crucial for managing advanced-stage tumors effectively.
Korean oncologists typically recommend radiotherapy over surgery for early-stage throat cancers when voice preservation is the priority. This approach offers success rates between 85% and 95% while protecting functional speech. It is also the preferred primary treatment for HPV-positive oropharyngeal cancers to maintain long-term swallowing capabilities.
Bookimed Expert Insight: While basic radiotherapy costs $25,000 to $30,000, top Seoul hospitals offer specialized proton therapy and IMRT. Leading centers such as Seoul National University Hospital and Severance Hospital have pioneered these digital workflows. These technologies reduce healthy tissue damage significantly compared to standard radiation protocols used elsewhere.
Patient Consensus: Patients report that staying in Seoul for the full 6–7 week treatment cycle is manageable. They appreciate how oncologists clearly explain the trade-offs between surgical scars and radiation-related swallowing changes.
Samsung Medical Center, Asan Medical Center, and Severance Hospital are top-tier facilities for throat cancer radiotherapy in South Korea. These centers utilize advanced technologies like Novalis, IGRT, and proton therapy to ensure high larynx preservation rates and precise tumor targeting for international patients.
Bookimed Expert Insight: While most top Seoul hospitals carry JCI or Newsweek honors, the real differentiator is volume-driven expertise. Samsung Medical Center manages over 2,000,000 patients annually. Their Radiation Oncology head, Professor Lim Do Hoon, has supervised 45,000+ treatments. This massive caseload translates to more refined dosimetry planning than smaller regional clinics.
Patient Consensus: Patients emphasize requesting the National Cancer Center or Samsung for proton therapy to preserve voice quality. They often suggest stocking saline rinses before treatment side effects peak in the third week.
South Korea currently hosts several active clinical trials for throat cancer radiotherapy, focusing on heavy ion therapy, proton beam `de-intensification,` and immunotherapy combinations. Major centers like Samsung Medical Center and Yonsei Cancer Center lead these initiatives to improve survival while reducing side effects like dry mouth.
Bookimed Expert Insight: While many think only of Seoul, our data shows institutional specialization is key. Samsung Medical Center, which treats over 2 million patients annually, often has the highest volume of Novalis and IGRT protocols. If you are seeking trials specifically for HPV-positive cases, these `presidential standard` hospitals often provide the most robust de-escalation programs that prioritize post-treatment quality of life.
Patient Consensus: Patients mention that HPV-positive status often opens doors to trials with fewer side effects. Many recommend using hospital English hotlines or dedicated messaging groups to get faster updates on eligibility and potential fee waivers.
Advanced radiotherapy technologies include Biology-Guided Radiotherapy, MR-Linac, and robotic systems like CyberKnife which provide sub-millimeter precision. Essential modalities for throat cancer in Republic of Korea include IGRT, Novalis, and Proton Beam Therapy. These JCI-accredited centers specialize in sparing critical structures like salivary glands while maximizing tumor dosage.
Bookimed Expert Insight: Samsung Medical Center and Severance Hospital consistently rank in Newsweek's World's Best Hospitals. Their infrastructure supports over 2 million patients annually, offering a high-volume experience that correlates with better outcomes. Samsung specialized centers integrate Novalis and IGRT technologies, ensuring precision that matches or exceeds North American standards.
Patient Consensus: Many patients highlight that Korean proton beam centers offer faster access than US facilities. They emphasize requesting dosimetry plans early to ensure maximum sparing of salivary glands and throat function.